1. Home
  2. WRAP vs CRBP Comparison

WRAP vs CRBP Comparison

Compare WRAP & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WRAP
  • CRBP
  • Stock Information
  • Founded
  • WRAP 2016
  • CRBP 2009
  • Country
  • WRAP United States
  • CRBP United States
  • Employees
  • WRAP N/A
  • CRBP N/A
  • Industry
  • WRAP Ordnance And Accessories
  • CRBP Biotechnology: Pharmaceutical Preparations
  • Sector
  • WRAP Industrials
  • CRBP Health Care
  • Exchange
  • WRAP Nasdaq
  • CRBP Nasdaq
  • Market Cap
  • WRAP 91.2M
  • CRBP 103.6M
  • IPO Year
  • WRAP N/A
  • CRBP N/A
  • Fundamental
  • Price
  • WRAP $2.11
  • CRBP $8.18
  • Analyst Decision
  • WRAP
  • CRBP Strong Buy
  • Analyst Count
  • WRAP 0
  • CRBP 8
  • Target Price
  • WRAP N/A
  • CRBP $61.38
  • AVG Volume (30 Days)
  • WRAP 163.9K
  • CRBP 296.4K
  • Earning Date
  • WRAP 11-14-2024
  • CRBP 03-11-2025
  • Dividend Yield
  • WRAP N/A
  • CRBP N/A
  • EPS Growth
  • WRAP N/A
  • CRBP N/A
  • EPS
  • WRAP N/A
  • CRBP N/A
  • Revenue
  • WRAP $4,231,000.00
  • CRBP N/A
  • Revenue This Year
  • WRAP N/A
  • CRBP N/A
  • Revenue Next Year
  • WRAP N/A
  • CRBP N/A
  • P/E Ratio
  • WRAP N/A
  • CRBP N/A
  • Revenue Growth
  • WRAP N/A
  • CRBP N/A
  • 52 Week Low
  • WRAP $1.21
  • CRBP $7.64
  • 52 Week High
  • WRAP $3.99
  • CRBP $61.90
  • Technical
  • Relative Strength Index (RSI)
  • WRAP 51.05
  • CRBP 35.10
  • Support Level
  • WRAP $1.92
  • CRBP $7.64
  • Resistance Level
  • WRAP $2.58
  • CRBP $9.51
  • Average True Range (ATR)
  • WRAP 0.15
  • CRBP 0.84
  • MACD
  • WRAP 0.02
  • CRBP -0.05
  • Stochastic Oscillator
  • WRAP 28.79
  • CRBP 13.71

About WRAP Wrap Technologies Inc.

Wrap Technologies Inc offers public safety technologies and services. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: